Tested batch: EP-260507-CI5
CJC-1295(without DAC)+ Ipamorelin (5/5mg) combines a growth hormone releasing hormone analog with a growth hormone secretagogue. Each box contains 10 vials of lyophilized powder, with 5mg CJC-1295 and 5mg Ipamorelin per vial. This blend is supplied as a research compound for laboratory use only.
Specifications: SKU CP10 · 10 vials of lyophilised powder per box · 5mg CJC-1295 (without DAC) + 5mg Ipamorelin per vial · measured net content 11.51 mg. Testing: four Kovera Labs reports for batch EP-260507-CI5: RP-HPLC purity 99.592%, endotoxin < 0.20 EU/mL, heavy metals and sterility – see the certificates below. Further reading: CJC-1295 (without DAC) + Ipamorelin in Australia: product overview and CJC-1295 (without DAC) + Ipamorelin: a research guide to evaluating suppliers. For laboratory research use only; not for human consumption.
Free shipping on all products.
This product is strictly intended for laboratory research use only. Not for human consumption. All products sold are for research purposes and should only be handled by qualified professionals in a controlled laboratory environment.
Tested batch: EP-260507-CI5 · 4 published certificates. Report library updated .
Batch EP-260507-CI5 – four Kovera Labs reports. Purity and identity: blend average purity 99.592% by RP-HPLC, blend net content 11.51 mg (KVR-2026-AC24F4, 29 June 2026). Endotoxin: < 0.20 EU/mL (ENDO-KVR-2026-AC24F4). Heavy metals: lead < 0.5, arsenic < 0.15, cadmium < 0.05 and mercury < 0.3 ppm (HM-KVR-2026-AC24F4). Sterility: no bacterial growth (aerobic and anaerobic) and no fungi or yeast detected after a 2-day incubation (RSTER-KVR-2026-AC24F4). Each certificate links to its Kovera Labs verification record, and the product image shows the same batch reference. For laboratory research use only.
| Test | Reported result | Report ID | Report date |
|---|---|---|---|
| Purity and Identity (COA) | KVR-2026-AC24F4 | 29 June 2026 | |
| Endotoxin | Endotoxin: < 0.20 EU/mL | ENDO-KVR-2026-AC24F4 | 30 May 2026 |
| Heavy Metals | Lead: < 0.5 ppm; Arsenic: < 0.15 ppm; Cadmium: < 0.05 ppm; Mercury: < 0.3 ppm | HM-KVR-2026-AC24F4 | 31 May 2026 |
| Sterility testing | Bacteria (aerobic/anaerobic): No microbial growth detected; Fungi / yeast: Not Detected; Incubation period: 2 days | RSTER-KVR-2026-AC24F4 | 30 May 2026 |
Read how to interpret and verify a Kovera Labs report or browse our testing standards and report directory.
Verify this certificate on Kovera Labs
| Reported test | Result | Stated criterion | Method, where stated |
|---|---|---|---|
| Blend average purity | 99.592 % | — | RP-HPLC |
| Blend net content | 11.51 mg | — | — |
| Arsenic (As) screening | Negative | — | — |
| Cadmium (Cd) screening | Negative | — | — |
| Lead (Pb) screening | Negative | — | — |
| Mercury (Hg) screening | Negative | — | — |
Verify this certificate on Kovera Labs
| Reported test | Result | Stated criterion | Method, where stated |
|---|---|---|---|
| Endotoxin | < 0.20 EU/mL | ≤ 0.5 | — |
| Final determination | PASS | — | — |
Verify this certificate on Kovera Labs
| Reported test | Result | Stated criterion | Method, where stated |
|---|---|---|---|
| Lead | < 0.5 ppm | ≤ 10 | ICP-MS |
| Arsenic | < 0.15 ppm | ≤ 1.5 | ICP-MS |
| Cadmium | < 0.05 ppm | ≤ 0.5 | ICP-MS |
| Mercury | < 0.3 ppm | ≤ 3 | ICP-MS |
Verify this certificate on Kovera Labs
| Reported test | Result | Stated criterion | Method, where stated |
|---|---|---|---|
| Bacteria (aerobic/anaerobic) | No microbial growth detected | — | — |
| Fungi / yeast | Not Detected | — | — |
| Incubation period | 2 days | — | — |
| Temperature | 30-35C | — | — |
| Final determination | SAMPLE PASSES STERILITY SCREEN | — | — |
Evidence reviews and laboratory guides relevant to CJC-1295 (no DAC) + Ipamorelin 5/5mg, plus the testing behind each batch.
Explore CJC-1295 Without DAC and Ipamorelin research, Australian buying guides and laboratory documentation.
